Fractyl Health (GUTS) Non Operating Income (2023 - 2026)
Fractyl Health (GUTS) reported Non Operating Income of $30.0 million for Q1 2026, up 143138.1% year-on-year from N/an in Q1 2025, and up 27.05% quarter-over-quarter from $23.6 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Non Operating Income data on file, last reported at $30.0 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 143138.1% year-over-year to $30.0 million; the trailing twelve-month figure through Mar 2026 stood at $29.0 million (up 4963.11% YoY), and the FY2025 full-year result was -$53000.0, down 12.77% from the prior year.
- Non Operating Income for Q1 2026 stood at $30.0 million, up from $23.6 million in the prior quarter.
- Across five years, Non Operating Income topped out at $30.0 million in Q1 2026 and bottomed at -$22.9 million in Q3 2025.
- A 4-year average of $394923.1 and a median of -$10000.0 in 2024 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 236520.0% in 2025, while the deepest fall reached 9955.56% in 2025.
- Tracing GUTS's Non Operating Income over 4 years: stood at -$6.2 million in 2023, then surged by 99.84% to -$10000.0 in 2024, then soared by 236520.0% to $23.6 million in 2025, then rose by 27.05% to $30.0 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $30.0 million, $23.6 million, and -$22.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 201.20 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 30.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.04 Mn |
| Dec 31, 2025 | 23.64 Mn |
| Sep 30, 2025 | -22.91 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Mar 31, 2025 | -21,000.00 |
| Dec 31, 2024 | -10,000.00 |
| Sep 30, 2024 | 621,000.00 |
| Jun 30, 2024 | -18,000.00 |
| Mar 31, 2024 | -10,000.00 |
| Dec 31, 2023 | -6.20 Mn |
| Sep 30, 2023 | -8,000.00 |
| Jun 30, 2023 | -18.36 Mn |
| Mar 31, 2023 | 175,000.00 |